Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy
1997

HPV and Skin Cancer in Kidney Transplant Patients

Sample size: 69 publication Evidence: moderate

Author Information

Author(s): MJ Arends, EC Benton, KM McLaren, LA Stark, JAA Hunter, CC Bird

Primary Institution: Edinburgh University Medical School

Hypothesis

Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus (HPV) DNA in skin tumors.

Conclusion

High-susceptibility renal allograft recipients developed significantly more aggressive skin cancers compared to those with intermediate or low susceptibility.

Supporting Evidence

  • 34 out of 69 renal allograft recipients developed skin cancers.
  • 56% of high-susceptibility patients had HPV DNA in their skin tumors.
  • 38% of high-susceptibility patients developed aggressive anogenital or cutaneous squamous cell cancers.

Takeaway

People who have had kidney transplants can get more skin cancers, especially if they are more likely to get sick from the sun or viruses like HPV.

Methodology

A clinicopathological survey of 69 renal allograft recipients was conducted, with follow-up periods of up to 28 years after transplantation, assessing the prevalence of HPV DNA in skin tumors.

Potential Biases

Variations in HPV activity and patient susceptibility may complicate the interpretation of results.

Limitations

The study had a small sample size and potential biases in patient selection and HPV detection methods.

Participant Demographics

The study included 69 renal allograft recipients, with a mix of male and female patients, and a mean age of 54 years.

Statistical Information

P-Value

0.005

Statistical Significance

p=0.005

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication